irinotecan has been researched along with Atrophy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dahlgren, D; Hellström, PM; Kullenberg, F; Lennernäs, H; Nygren, P; Peters, K; Rosenqvist, E; Sjöblom, M | 1 |
Al-Azri, AR; Bowen, JM; Gibson, RJ; Keefe, DM; Logan, RM; Stringer, AM | 1 |
Guffroy, M; Hodge, T | 1 |
3 other study(ies) available for irinotecan and Atrophy
Article | Year |
---|---|
Evaluation and validation of chemotherapy-specific diarrhoea and histopathology in rats.
Topics: Animals; Antineoplastic Agents; Atrophy; Body Weight; Diarrhea; Doxorubicin; Fluorouracil; Idarubicin; Intestinal Mucosa; Irinotecan; Male; Methotrexate; Mucositis; Rats; Rats, Wistar | 2022 |
Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis.
Topics: Analysis of Variance; Animals; Atrophy; Camptothecin; Disease Models, Animal; Female; Immunohistochemistry; Irinotecan; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Mouth Mucosa; Random Allocation; Rats; Stomatitis; Tongue | 2015 |
Re:Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Atrophy; Camptothecin; Cecum; Cisplatin; Diarrhea; Ileum; Intestinal Mucosa; Irinotecan; Mice | 1996 |